Topic description and stories

The bug hunters and the microbiome

21 Jun 2017

Trevor Lawley and Gordon Dougan are bug hunters, albeit not the conventional kind. The bugs they collect are invisible to the naked eye. And even...

Read more

Apollo's mission to drive therapeutic innovation

20 Jun 2017

The stirrings of a revolution are starting to ripple through hundreds of laboratories. It’s a revolution that aims to result in new medicines –...

Read more

Take your medicine: how research into supply chains will help you take care of yourself

14 Jun 2017

Researchers are working with pharmaceutical companies to make improvements across the whole supply chain, from how a pill is made to the moment it is...

Read more

Future therapeutics: the hundred-year horizon scan

13 Jun 2017

How will precision medicine define 21st-century therapeutics? What will future healthcare look like? And what actually lies ‘beyond the pill’...

Read more
pharmaceuticals

How bright is your digital future?

18 Jan 2017

Dr Jag Srai, Head of the Centre for International Manufacturing at Cambridge's Institute for Manufacturing, and colleagues are developing new ways to...

Read more

Financial cycles of acquisitions and ‘buybacks’ threaten public access to breakthrough drugs

28 Jul 2016

An analysis of a new drug’s journey to market, published today in the BMJ, shines a light on financial practices that see some major pharmaceutical...

Read more

Pills

Opinion: More accountability needed in how drugs are priced and reimbursed

23 May 2016

Lawrence King (Department of Sociology) and Piotr Ozieranski (University of Bath) discuss how EU member states use complex policy instruments to...

Read more

GSK/Cambridge Strategic Partnership aims to develop next wave of ‘game-changing’ medicines

23 Nov 2015

GSK, the University of Cambridge and Cambridge University Hospitals NHS Foundation Trust today announce their Strategic Partnership, with the long-...

Read more
Lab tubes (cropped)

Cambridge researchers and pharma in innovative new consortium to develop and study early stage drugs

28 Jul 2015

An innovative new Consortium will act as a ‘match-making’ service between pharmaceutical companies and researchers in Cambridge with the aim of...

Read more

By tracing the pathway by which paracetamol becomes toxic in the body back to a single molecular initiating event, researchers were able to predict with accuracy the likely toxic effects of other compounds with similar molecular features.

Molecular event mapping opens door to more tests “in silico”

18 Nov 2014

Scientists report a new method for establishing whether chemical compounds are safe for human use without "in vivo" testing, based on so-called "...

Read more
When twisted light matches the twist of nanostructures, strong interactions with chiral molecules could arise

Exposing ‘evil twins’

16 May 2014

A combination of nanotechnology and a unique twisting property of light could lead to new methods for ensuring the purity and safety of...

Read more

Towards the ‘holy grail’ of anticoagulant drugs

17 Jun 2013

New Cambridge spin-out raises $11 million in funding to develop revolutionary new drug for thrombosis, which causes heart attacks and strokes.

Read more

Pages